Swandal Craig A. 4
4 · Apyx Medical Corp · Filed Mar 5, 2020
Insider Transaction Report
Form 4
Swandal Craig A.
Director
Transactions
- Exercise of In-Money
Common Stock
2019-01-10$2.37/sh+10,000$23,700→ 10,000 total - Exercise of In-Money
Common Stock
2019-01-10$5.30/sh+8,000$42,400→ 18,000 total - Exercise of In-Money
Stock Option (Option to Buy)
2019-01-10$2.37/sh−10,000$23,700→ 2,000 totalExercise: $2.37From: 2019-03-09Exp: 2028-03-09→ Common Stock (10,000 underlying) - Exercise of In-Money
Stock Option (Option to Buy)
2019-01-10$5.30/sh−8,000$42,400→ 16,000 totalExercise: $5.30From: 2019-08-30Exp: 2028-08-29→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.